動物バイオテクノロジー市場：製品別、用途別-2025～2030年の世界予測

動物バイオテクノロジー市場の2023年の市場規模は286億4,000万米ドルで、2024年には310億4,000万米ドルに達すると予測され、CAGR 8.46％で成長し、2030年には505億9,000万米ドルに達すると予測されています。

動物バイオテクノロジーは、動物の繁殖、健康、生産性、効率の改善を目的とした、動物またはその生物学的実体による物質の処理または生産への科学的と工学的原理の適用を包含します。このセグメントは、環境ストレスに耐え、より栄養価の高いミルクや肉を生産し、世界の食糧需要、医薬品、農業生産性に対応するよう調整された生物学的解決策を提供できる、遺伝子工学的に強化された動物を開発するために不可欠です。このセグメントでの応用は、遺伝子工学、クローニング、バイオ医薬品の生産にまで及びます。最終用途は、農業、製薬、動物の健康と生産効率の向上を目指す研究機関などがあります。

市場成長は、世界人口の増加、食糧安全保障への懸念の高まり、サステイナブル農業プロセスへのシフトの影響を受けています。ゲノミクスやCRISPR/Cas9のような遺伝子編集技術といったバイオテクノロジーの革新が進歩を促し、作物や家畜の強健性に寄与します。しかし、家畜の疾病管理、バイオ医薬品の生産、動物福祉基準の改善にも潜在的なビジネス機会があります。研究開発に投資する企業は、学術・研究機関とのパートナーシップを活用することで、イノベーションを促進し、製品ラインを拡大することができます。市場は、倫理的な議論、厳しい規制の枠組み、限られた消費者の認識といった課題に直面しており、これが急速な普及を妨げる可能性があります。こうした限界に対処するには、受容とコンプライアンスを確保するための強固な規制戦略とともに、利益、リスク、倫理的配慮に関する透明性のあるコミュニケーションが必要です。

技術革新の可能性のあるセグメントとしては、次世代シーケンシング、遺伝子編集の進歩、精密畜産のための統合バイオインフォマティクスなどがあります。さらに、世界の協力関係や異業種間のパートナーシップに注力することで、多様化と拡大性が強化される可能性があります。この市場の性質はダイナミックであり、サステイナブル実践と倫理的配慮が重視されます。成長を目指す企業は、革新性と規制遵守を育みながら機敏に行動し、動物バイオテクノロジーの複雑な状況を乗り切らなければならないです。倫理的・規制的懸念に対処し、消費者の信頼を培うことで、企業は畜産と医療ソリューションにおけるバイオテクノロジーの進歩に対する急増する需要を取り込むことができます。

市場力学：急速に進化する動物バイオテクノロジー市場の主要市場洞察を公開

動物バイオテクノロジー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • クローン動物とトランスジェニック動物への注目の高まり
  • 規制当局の承認と相まって高まる人気と受容性
  • 動物用医薬品の開発と動物の予防医療
• 市場抑制要因
  • 動物バイオテクノロジー製品に関連する高コストの倫理的問題
• 市場機会
  • 食肉消費量の増加と一人当たりの動物医療費の増加
  • 農業用トランスジェニック家畜の生産
• 市場課題
  • 食品による人体への健康影響の可能性

ポーターのファイブフォース：動物バイオテクノロジー市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物バイオテクノロジー市場における外部からの影響の把握

外部マクロ環境要因は、動物バイオテクノロジー市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：動物バイオテクノロジー市場における競合情勢の把握

動物バイオテクノロジー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：動物バイオテクノロジー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物バイオテクノロジー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：動物バイオテクノロジー市場における成功への道筋を描く

動物バイオテクノロジー市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • クローンや遺伝子組み換え動物への注目が高まる
    • 規制当局の承認と相まって人気と受容が高まっている
    • 動物用医薬品の開発と動物の予防ケア
  • 抑制要因
    • 動物バイオテクノロジー製品に関連する高コストの倫理的問題
  • 機会
    • 動物の肉の消費量の増加と一人当たりの動物医療費の上昇
    • 農業用遺伝子組み換え家畜の生産
  • 課題
    • 食品による人体への潜在的な健康影響
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 動物バイオテクノロジー市場：製品別

• イントロダクション
• 診断テスト
• 薬剤
• 生殖と遺伝子製品
• ワクチン

第7章 動物バイオテクノロジー市場：用途別

• イントロダクション
• 動物用医薬品の開発
• 食品安全と医薬品開発
• 動物の予防ケア

第8章 南北アメリカの動物バイオテクノロジー市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の動物バイオテクノロジー市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの動物バイオテクノロジー市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Bayer AG
• BioChek BV
• Biogenesis Bago
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Heska Corporation
• Hester Biosciences Limited
• IDEXX Laboratories, Inc.
• Indian Immunologicals Ltd.
• Intervet Inc.
• Kareo, Inc.
• Merck & Co., Inc.
• Sanofi-Aventis Groupe S.A.
• Santa Cruz BIoTechnology, Inc.
• Virbac S.A.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. ANIMAL BIOTECHNOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL BIOTECHNOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL BIOTECHNOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REPORDUCTIVE & GENETIC PRODUTCS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DEVELOPMENT OF ANIMAL PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FOOD SAFETY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PREVENTIVE CARE FOR ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. POLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. POLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The Animal Biotechnology Market was valued at USD 28.64 billion in 2023, expected to reach USD 31.04 billion in 2024, and is projected to grow at a CAGR of 8.46%, to USD 50.59 billion by 2030.

Animal biotechnology encompasses the application of scientific and engineering principles to the processing or production of materials by animals or their biological entities, aiming to improve animal breeding, health, productivity, and efficiencies. This field is essential for developing genetically enhanced animals that can withstand environmental stresses, produce more nutritionally enriched milk or meat, and provide biologically based solutions tailored to address global food demands, pharmaceuticals, and agricultural productivity. Applications in this area extend to genetic engineering, cloning, and the production of bio-pharmaceuticals. The end-use scope covers agriculture, pharmaceuticals, and research institutions seeking to enhance animal health and production efficiencies.

Market growth is influenced by the rising global population, increasing food security concerns, and the shift towards sustainable agricultural processes. Biotechnology innovations such as genomics and gene-editing technologies like CRISPR/Cas9 drive advancements, contributing to crop and livestock robustness. However, potential opportunities lie in disease management in livestock, biopharmaceutical production, and improving animal welfare standards. Companies investing in research and development can leverage partnerships with academic and research institutions to foster innovation and expansive product lines. The market faces challenges like ethical debates, stringent regulatory frameworks, and limited consumer awareness, which may impede rapid adoption. Addressing these limitations requires transparent communication about benefits, risks, and ethical considerations, in conjunction with robust regulatory strategies to ensure acceptance and compliance.

The potential areas for innovation include next-generation sequencing, gene-editing advancements, and integrative bioinformatics for precision animal farming. Furthermore, focusing on global collaborations and cross-industry partnerships could bolster diversification and scalability. The nature of this market is dynamic, with a strong emphasis on sustainable practices and ethical considerations. Companies seeking growth must remain agile, fostering innovation and regulatory compliance to navigate the complex landscape of animal biotechnology. By addressing ethical and regulatory concerns and cultivating consumer trust, businesses can tap into the burgeoning demand for biotechnological advancements in animal agriculture and healthcare solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Biotechnology Market

The Animal Biotechnology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising focus toward cloning and transgenic animals
  • Growing popularity and acceptance coupled with the regulatory approvals
  • Development of animal pharmaceuticals and preventive care for animals
• Market Restraints
  • High cost ethical issues associated with the animal biotechnology products
• Market Opportunities
  • Increasing animal meat consumption and the rising per capita animal healthcare expenditure
  • Production of transgenic livestock for agriculture
• Market Challenges
  • Potential health effects to humans from food product

Porter's Five Forces: A Strategic Tool for Navigating the Animal Biotechnology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Biotechnology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Biotechnology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Biotechnology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Biotechnology Market

A detailed market share analysis in the Animal Biotechnology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Biotechnology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Biotechnology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Biotechnology Market

A strategic analysis of the Animal Biotechnology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Biotechnology Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, BioChek BV, Biogenesis Bago, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Intervet Inc., Kareo, Inc., Merck & Co., Inc., Sanofi-Aventis Groupe S.A., Santa Cruz Biotechnology, Inc., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Biotechnology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs, and Vaccines.
• Based on Application, market is studied across Development of Animal Pharmaceuticals, Food Safety & Drug Development, and Preventive Care for Animals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising focus toward cloning and transgenic animals
    • 5.1.1.2. Growing popularity and acceptance coupled with the regulatory approvals
    • 5.1.1.3. Development of animal pharmaceuticals and preventive care for animals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost ethical issues associated with the animal biotechnology products
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing animal meat consumption and the rising per capita animal healthcare expenditure
    • 5.1.3.2. Production of transgenic livestock for agriculture
  • 5.1.4. Challenges
    • 5.1.4.1. Potential health effects to humans from food product
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Biotechnology Market, by Product

• 6.1. Introduction
• 6.2. Diagnostic Tests
• 6.3. Drugs
• 6.4. Reporductive & Genetic Produtcs
• 6.5. Vaccines

7. Animal Biotechnology Market, by Application

• 7.1. Introduction
• 7.2. Development of Animal Pharmaceuticals
• 7.3. Food Safety & Drug Development
• 7.4. Preventive Care for Animals

8. Americas Animal Biotechnology Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Animal Biotechnology Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Animal Biotechnology Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bayer AG
• 2. BioChek BV
• 3. Biogenesis Bago
• 4. Boehringer Ingelheim International GmbH
• 5. Elanco Animal Health Incorporated
• 6. Heska Corporation
• 7. Hester Biosciences Limited
• 8. IDEXX Laboratories, Inc.
• 9. Indian Immunologicals Ltd.
• 10. Intervet Inc.
• 11. Kareo, Inc.
• 12. Merck & Co., Inc.
• 13. Sanofi-Aventis Groupe S.A.
• 14. Santa Cruz Biotechnology, Inc.
• 15. Virbac S.A.
• 16. Zoetis Inc.